Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Life Genomics AB
AB
Active
Org 5569931891
Odinsgatan 28, 411 03
Göteborg
Diagnostic imaging services and medical laboratory activities
·
NACE 8691
Est. 2014 · 11 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Diagnostic imaging services and medical laboratory activities
/
Life Genomics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
153M
115M
77M
38M
0M
2020: 23M
23M
2020
2021: 123M (+435% vs 2020)
123M
+435%
2021
2022: 46M (-63% vs 2021)
46M
-63%
2022
2023: 30M (-35% vs 2022)
30M
-35%
2023
2024: 30M (0% vs 2023)
30M
0%
2024
EBITDA
SEK millions
84M
50M
16M
-18M
-52M
2020: 1M
1M
2020
2021: 57M (+5600% vs 2020)
57M
+5600%
2021
2022: -25M (-144% vs 2021)
-25M
-144%
2022
2023: -5M (+80% vs 2022)
-5M
+80%
2023
2024: -2M (+60% vs 2023)
-2M
+60%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
29 594
29 974
45 802
122 811
23 263
Staff expenses
—
—
—
—
—
EBITDA
−1 959
−4 936
−24 620
56 508
1 429
Depreciation & amort.
−397
−528
−5 595
−2 921
−332
EBIT
−2 356
−5 464
−30 215
53 587
1 097
Net financials
444
295
−88
—
−6
Profit before tax
−1 911
−5 169
−17 194
40 477
1 092
Tax
−0
−0
1 557
−5 130
−0
Net profit
−1 911
−5 169
−15 637
35 347
1 092
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
24 011
25 872
43 356
68 677
9 625
Equity
18 621
20 532
25 702
41 338
5 991
Long-term debt
0
0
0
0
0
Short-term debt
5 390
5 340
17 655
14 230
3 634
Total debt
5 390
5 340
17 655
14 230
3 634
Financial ratios
5-year trend
EBITDA margin
−6,6 %
This company
15,8 %
Market median
This company
Market median
142% below market
2020
2024
Equity ratio
77,6 %
This company
38,2 %
Market median
This company
Market median
103% above market
2020
2024
Return on equity
−10,3 %
This company
18,4 %
Market median
This company
Market median
156% below market
2020
2024
Net profit margin
−6,5 %
This company
8,1 %
Market median
This company
Market median
180% below market
2020
2024
Asset turnover
1,23×
This company
1,12×
Market median
This company
Market median
10% above market
2020
2024
Debt / equity
0,29×
This company
0,62×
Market median
This company
Market median
53% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Life Genomics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
